Antibody levels in people with diabetes after one dose of the ChAdOx1 nCoV-19 (AZD1222) vaccine

por Rangsrisaeneepitak, Vimonsri, Porntharukchareon, Thachanun, Dechates, Bothamai, Sirisreetreerux, Supamas, Tawinprai, Kriangkrai
Publicado 2022

Dynamics of anti-RBD (anti-receptor binding domain) levels in diabetes patients following the ChAdOx1 nCoV-19 vaccine (AZD1222) in the Thai population

por Sirisreetreerux, Supamas, Porntharukchareon, Thachanun, Dechates, Bothamai, Rangsrisaeneepitak, Vimonsri, Therawit, Phonthip, Worawitchawong, Supanat, Sornsamdang, Gaidganok, Soonklang, Kamonwan, Tawinprai, Kriangkrai
Publicado 2023

The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort study

por Porntharukchareon, Thachanun, Chartisathian, Wipada, Navinpipat, Manassamon, Samdaengpan, Chayanee, Cheirsilpa, Kunsuda, Lueprasitsakul, Aimwipa, Worawichawong, Supanat, Muangsillapasart, Viroj, Pumuthaivirat, Pratya, Dechates, Bothamai, Sirisreetreerux, Supamas, Siripongboonsitti, Taweegrit, Rangsrisaeneepitak, Vimonsri, Jirawattanapalin, Kerati, Tawinprai, Kriangkrai
Publicado 2023